Pluri Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Pluri Inc. stock issued during period, value, issued for services for the quarter ending 2016-06-30 was $0.00.
- Pluri Inc. stock issued during period, value, issued for services for the quarter ending 2016-03-31 was $0.00.
- Pluri Inc. stock issued during period, value, issued for services for the quarter ending 2015-12-31 was -$26.00K.
- Pluri Inc. stock issued during period, value, issued for services for the quarter ending 2015-09-30 was $65.00K.
- Pluri Inc. stock issued during period, value, issued for services for fiscal 2016 was $39.00K, a 85.17% decline from fiscal 2015.
- Pluri Inc. stock issued during period, value, issued for services for fiscal 2015 was $263.00K.
- Pluri Inc. stock issued during period, value, issued for services for fiscal 2013 was $1.40M, a 61.87% decline from fiscal 2012.
- Pluri Inc. stock issued during period, value, issued for services for fiscal 2012 was $3.67M.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-12 | $39.00K 10-K · filed 2018-09-12 |
| 2016-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08 | |
| 2015-12-31 | -$26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-08 | |
| 2015-09-30 | $65.00K 10-Q · filed 2016-11-07 | |
| 2015-06-30 | $263.00K 10-K · filed 2017-09-07 | |
| 2013-06-30 | $1.40M 10-K · filed 2015-09-09 | |
| 2012-06-30 | $3.67M 10-K · filed 2014-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |